Childhood maltreatment is not associated with atopic dermatitis in adults: results from a cross-sectional population-based cohort study - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35920760/
This is the first study investigating the association of CM with AD in adults. CM was common in the present general population sample, emphasizing that CM is an important public...
Conclusion: Our findings suggest that CM is not a risk factor for AD. It might be hypothesized that AD severity is a crucial outcome, and that CM history is a factor with impact on disease severity and course rather than a risk factor for the development of AD.
A Practical Approach to Perusing the Atopic Dermatitis Product Portfolio for Pediatric Patients - JDDonline - Journal of Drugs in Dermatology
Amy Paller, MD & Adam Friedman, MD, FAAD For the millions of Atopic Dermatitis suffers, recent months have heralded a new age of both topical and system options to quench...
Discussion: For the millions of Atopic Dermatitis suffers, recent months have heralded a new age of both topical and system options to quench the flames of disease.
Investigating Patient Preferences for Atopic Dermatitis Treatment
Source : https://www.ajmc.com/view/investigating-patient-preferences-for-atopic-dermatitis-treatment
Patient preferences for treatment in adults with atopic dermatitis (AD) highlight the value of oral administration, less frequent monitoring, and rapid onset-even at the expense of reduced efficacy. Study findings...
Conclusion: Regarding patient preferences, participants most valued increasing the chance of achieving a meaningful reduction in itch at week 16 from 20% to 50%, followed by reducing the risks of serious infections from 6% to 0% and of eye inflammation from 20% to 0%.
Examining the Impact of Atopic Dermatitis Severity on Families of Pediatric Patients
Increased atopic dermatitis (AD) severity in pediatric patients was associated with a greater physical, emotional, social, and economic impact on families, according to study findings published in The Journal of...
Discussion: "These results emphasize that the burden of AD and its treatment extends beyond the individual patient and potentially impacts parents and caregivers who are committed to meeting the caregiving needs of their children, especially at higher levels of disease severity,” concluded the study authors.
Efficacy of a 3% Kānuka oil cream for the treatment of moderate-to-severe eczema: A single blind randomised vehicle-controlled trial
Source : https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(22)00291-7/fulltext
The KO group had a significant improvement in POEM score compared to VC. Rates of adverse events and withdrawals were similar between groups with no serious adverse events reported. Treatment...
Discussion: This randomised controlled trial of adults with self-reported moderate to severe eczema, found the use of a kānuka oil cream to be a safe and effective emollient therapy. Both creams were well tolerated by participants, with low rates of adverse events and withdrawals, and positive global acceptability ratings.